Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Muscle Recovery and Fatigue

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...

Fatigue

Fatigue

Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Elevated serum levels of interleukin-11 and matrix metalloproteinase-9 in myalgic encephalomyelitis/chronic fatigue syndrome.

Frontiers in immunology·2026

Same author

Toward a Molecular Reclassification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Integrating Multi-Omics, Machine Learning, and Precision Medicine.

International journal of molecular sciences·2026

Same author

GPU-accelerated modeling of biological regulatory networks.

Scientific reports·2026

Same author

Neurosenescence, inflammaging and neuroinflammation in neurodegenerative disorders.

Frontiers in aging·2026

Same author

Computational modeling-directed combination treatment with etanercept and mifepristone mitigates neuroinflammation in a mouse model of Gulf War Illness.

PloS one·2026

Same author

Corticosteroid Usage in Modeling Gulf War Illness in Pre-Clinical Models: A Systematic Review.

International journal of molecular sciences·2025

Search research articles

Related Experiment Video

Updated: May 21, 2026

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue

Published on: May 17, 2018

Biomarkers for chronic fatigue.

Nancy G Klimas¹, Gordon Broderick, Mary Ann Fletcher

¹Miami Veterans Affairs Medical Center, Miami, FL, USA. Nancy.Klimas@va.gov

Brain, Behavior, and Immunity

|June 27, 2012

Summary

This summary is machine-generated.

Chronic fatigue syndrome (CFS/ME) lacks objective diagnostic markers. This review explores potential biomarkers across nervous, endocrine, and immune systems to aid diagnosis and treatment development.

More Related Videos

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse

Published on: May 31, 2016

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer

Published on: February 20, 2020

Related Experiment Videos

Last Updated: May 21, 2026

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue

Published on: May 17, 2018

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse

Published on: May 31, 2016

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer

Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer

Published on: February 20, 2020

Area of Science:

Neuroscience
Immunology
Endocrinology

Background:

Chronic fatigue, persisting over six months, is a primary symptom.
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is defined by chronic fatigue plus at least four of eight specific symptoms, excluding other diseases.
Potential causes include inflammation, immune activation, autonomic dysfunction, and neuroendocrine dysregulation.

Purpose of the Study:

To review recent literature on biomarkers for fatigue in CFS/ME.
To compare CFS/ME biomarkers with those from other diseases.
To highlight the need for objective markers for diagnosis and treatment.

Main Methods:

Literature review of recent studies on CFS/ME biomarkers.
Comparative analysis of biomarkers across different conditions.
Focus on markers within nervous, endocrine, and immune systems.

Main Results:

Biomarkers for fatigue are found across multiple regulatory systems.
CFS/ME presents as a complex condition involving nervous, endocrine, and immune system alterations.
Current diagnostic criteria rely solely on symptoms, lacking objective measures.

Conclusions:

Identifying consistent, objective biomarkers is crucial for CFS/ME diagnosis and treatment.
An integrative molecular profiling approach is needed to understand CFS/ME pathogenesis.
Effective treatment development is hindered without a clear molecular signature.